Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 7Blastic Plasmacytoid Dendritic Cell Neoplasm 3Myelodysplastic Syndromes 2Hematologic Neoplasms 2Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hodgkin Disease 1

Interventions

Cyclophosphamide 56fludarabine 30Methotrexate 24blinatumomab 22Dexamethasone 21Cytarabine 21Vincristine 19venetoclax 18Specimen Handling 16fludarabine phosphate 15Whole-Body Irradiation 13Stem Cell Transplantation 12Biopsy 12Tacrolimus 10Mycophenolic Acid 10Daunorubicin 10Thiotepa 9Rituximab 9Prednisone 9Mercaptopurine 9Melphalan 9Immunotherapy, Adoptive 9Magnetic Resonance Spectroscopy 8Doxorubicin 8pegaspargase 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7olverembatinib 6Mesna 6Inotuzumab Ozogamicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × tagraxofusp × Clear all
NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡